NO20021255L - Nye cellecykelsjekkpunktsgener og proteiner kodet derav - Google Patents

Nye cellecykelsjekkpunktsgener og proteiner kodet derav

Info

Publication number
NO20021255L
NO20021255L NO20021255A NO20021255A NO20021255L NO 20021255 L NO20021255 L NO 20021255L NO 20021255 A NO20021255 A NO 20021255A NO 20021255 A NO20021255 A NO 20021255A NO 20021255 L NO20021255 L NO 20021255L
Authority
NO
Norway
Prior art keywords
cell cycle
proteins encoded
cycle checkpoint
new cell
checkpoint genes
Prior art date
Application number
NO20021255A
Other languages
English (en)
Other versions
NO20021255D0 (no
Inventor
Paul R Russell
Jorge E Vialard
Michael N Boddy
Paul A Shanahan
Antonia Lopez-Girona
Cecile-Marie D D Denis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20021255D0 publication Critical patent/NO20021255D0/no
Publication of NO20021255L publication Critical patent/NO20021255L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20021255A 1999-09-14 2002-03-13 Nye cellecykelsjekkpunktsgener og proteiner kodet derav NO20021255L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15383699P 1999-09-14 1999-09-14
PCT/US2000/025278 WO2001020038A1 (en) 1999-09-14 2000-09-14 Novel cell cycle checkpoint genes and proteins encoded thereby

Publications (2)

Publication Number Publication Date
NO20021255D0 NO20021255D0 (no) 2002-03-13
NO20021255L true NO20021255L (no) 2002-05-03

Family

ID=22548950

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021255A NO20021255L (no) 1999-09-14 2002-03-13 Nye cellecykelsjekkpunktsgener og proteiner kodet derav

Country Status (15)

Country Link
US (3) US6440732B1 (no)
EP (1) EP1214453B1 (no)
JP (1) JP4871468B2 (no)
KR (2) KR100851511B1 (no)
AT (1) ATE404693T1 (no)
AU (1) AU784443B2 (no)
CA (1) CA2385266C (no)
DE (1) DE60039895D1 (no)
DK (1) DK1214453T3 (no)
ES (1) ES2311472T3 (no)
IL (2) IL148595A0 (no)
NO (1) NO20021255L (no)
NZ (1) NZ518236A (no)
WO (1) WO2001020038A1 (no)
ZA (1) ZA200202863B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1578767A4 (en) * 2002-12-04 2008-01-09 Algos Therapeutics Inc METHOD AND MATERIALS FOR MODULATING TRPM2
US7396669B2 (en) * 2004-06-30 2008-07-08 The Scripps Research Institute Mammalian endonucleases and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801154A (en) * 1993-10-18 1998-09-01 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of multidrug resistance-associated protein
US5552390A (en) * 1993-12-09 1996-09-03 The Board Of Regents Of The University Of Nebraska Phosphorothioate inhibitors of metastatic breast cancer
AU6764398A (en) * 1997-03-20 1998-10-12 Variagenics, Inc. Target genes for allele-specific drugs
US5977341A (en) * 1998-11-20 1999-11-02 Isis Pharmaceuticals Inc. Antisense modulation of inhibitor-kappa B kinase-beta expression
US7396669B2 (en) * 2004-06-30 2008-07-08 The Scripps Research Institute Mammalian endonucleases and methods of use

Also Published As

Publication number Publication date
DE60039895D1 (de) 2008-09-25
EP1214453B1 (en) 2008-08-13
EP1214453A1 (en) 2002-06-19
ES2311472T3 (es) 2009-02-16
CA2385266A1 (en) 2001-03-22
JP4871468B2 (ja) 2012-02-08
KR100817010B1 (ko) 2008-03-27
NO20021255D0 (no) 2002-03-13
US20070072794A1 (en) 2007-03-29
JP2003509069A (ja) 2003-03-11
KR20070043872A (ko) 2007-04-25
US7479541B2 (en) 2009-01-20
DK1214453T3 (da) 2008-10-13
ZA200202863B (en) 2003-09-23
AU7581700A (en) 2001-04-17
US6440732B1 (en) 2002-08-27
US20070213256A1 (en) 2007-09-13
NZ518236A (en) 2004-02-27
CA2385266C (en) 2011-05-24
IL148595A (en) 2008-11-26
IL148595A0 (en) 2002-09-12
WO2001020038A1 (en) 2001-03-22
KR100851511B1 (ko) 2008-08-11
EP1214453A4 (en) 2003-02-19
AU784443B2 (en) 2006-04-06
KR20020064781A (ko) 2002-08-09
ATE404693T1 (de) 2008-08-15
US7214790B2 (en) 2007-05-08

Similar Documents

Publication Publication Date Title
DE69534733D1 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
ES2177475T1 (es) Genes de corynebacterium glutamicum que codifican proteinas de una ruta metabolica.
PL1824977T3 (pl) Promotorowy kwas nukleinowy pochodzący z rodzaju Corynebacterium, kaseta ekspresyjna zawierająca promotor i wektor, komórka gospodarza zawierająca wektor i sposób ekspresji genu z użyciem komórki
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
AU2002360331A8 (en) Egviii endoglucanase and nucleic acids encoding the same
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
DE60328715D1 (de) Polypeptide mit cellobiohydrolase ii-aktivität und dafür kodierende polynucleotide
NO20020861L (no) Nye B7-4-molekyler og anvendelser derav
DE69943068D1 (de) Transfer von mRNA unter Verwendung von polykationischen Verbindungen
DK127786D0 (da) Fremgangsmaade til fremstilling af tgf-beta, dna og mrna, som koder for tgf-beta, samt replicerbare vektorer omfattende dna'en og vaertscellerindeholdende vektorerne
DE60129028D1 (de) Zelluläre arrays zur identifizierung von veränderter genexpression
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
ATE488591T1 (de) Neuer l-lysin-induzierbarer promotor
DK2186530T3 (da) Promotere, der udviser endothelcellespecificitet og fremgangsmåder til anvendelse heraf
NO20021255D0 (no) Nye cellecykel-sjekkpunktsgener og proteiner kodet derav
ZA200404424B (en) Genes encoding for genetic stability, gene expression and folding proteins.
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
WO2003066867A3 (en) Genetically engineered phic31-integrase genes
DK1032683T3 (da) Polypeptider med 5-aminolevulinsyre-syntase-aktivitet og nukleinsyrer, der koder for disse
DK1226236T3 (da) Polypeptider, der har glucanotransferase-aktivitet, og nucleinsyrer, som koder disse
ATE547427T1 (de) Verfahren zur rekombinanten herstellung von ribonukleoproteinen
WO2005017176A3 (en) Methods for identifying risk of melanoma and treatments thereof
DE59914061D1 (de) Das gen prv-1 und dessen verwendung
DE69840051D1 (de) Durch wnt-1 induzierbare gene

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application